Toward Tailoring the Degradation Rate of Magnesium-Based Biomaterials for Various Medical Applications: Assessing Corrosion, Cytocompatibility and Immunological Effects.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Jan 2021
Historique:
received: 30 11 2020
revised: 11 01 2021
accepted: 13 01 2021
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 7 9 2021
Statut: epublish

Résumé

Magnesium (Mg)-based biomaterials hold considerable promise for applications in regenerative medicine. However, the degradation of Mg needs to be reduced to control toxicity caused by its rapid natural corrosion. In the process of developing new Mg alloys with various surface modifications, an efficient assessment of the relevant properties is essential. In the present study, a WE43 Mg alloy with a plasma electrolytic oxidation (PEO)-generated surface was investigated. Surface microstructure, hydrogen gas evolution in immersion tests and cytocompatibility were assessed. In addition, a novel in vitro immunological test using primary human lymphocytes was introduced. On PEO-treated WE43, a larger number of pores and microcracks, as well as increased roughness, were observed compared to untreated WE43. Hydrogen gas evolution after two weeks was reduced by 40.7% through PEO treatment, indicating a significantly reduced corrosion rate. In contrast to untreated WE43, PEO-treated WE43 exhibited excellent cytocompatibility. After incubation for three days, untreated WE43 killed over 90% of lymphocytes while more than 80% of the cells were still vital after incubation with the PEO-treated WE43. PEO-treated WE43 slightly stimulated the activation, proliferation and toxin (perforin and granzyme B) expression of CD8

Identifiants

pubmed: 33478090
pii: ijms22020971
doi: 10.3390/ijms22020971
pmc: PMC7835942
pii:
doi:

Substances chimiques

Coated Materials, Biocompatible 0
Magnesium Compounds 0
Magnesium I38ZP9992A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SM 214/4-1
Organisme : Deutsche Forschungsgemeinschaft
ID : WA 1672/40-1

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

In Vivo. 2018 Mar-Apr;32(2):241-247
pubmed: 29475905
Acta Biomater. 2014 Nov;10(11):4561-4573
pubmed: 25034646
J Biomed Mater Res B Appl Biomater. 2012 Aug;100(6):1691-701
pubmed: 22566412
Acta Biomater. 2010 May;6(5):1749-55
pubmed: 20051271
Acta Biomater. 2013 Nov;9(10):8643-9
pubmed: 22963846
Acta Biomater. 2011 Apr;7(4):1452-9
pubmed: 21145436
J Biomim Biomater Tissue Eng. 2012 Feb 3;12:25-39
pubmed: 22408600
Acta Biomater. 2015 Sep;23:354-363
pubmed: 26073090
Biomaterials. 2006 Mar;27(9):1728-34
pubmed: 16246414
Int J Mol Sci. 2019 Sep 30;20(19):
pubmed: 31574947
Cells. 2020 Jul 22;9(8):
pubmed: 32707842
Acta Biomater. 2013 Feb;9(2):5411-20
pubmed: 23022544
Int J Mol Sci. 2019 Jan 10;20(2):
pubmed: 30634646
Bioact Mater. 2020 Mar 30;5(2):398-409
pubmed: 32258829

Auteurs

Philip Hartjen (P)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.

Nils Wegner (N)

Department of Materials Test Engineering (WPT), TU Dortmund University, Baroper Str. 303, D-44227 Dortmund, Germany.

Parimah Ahmadi (P)

First Department of Medicine, Division of Infectious Diseases, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.

Levi Matthies (L)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.

Ola Nada (O)

Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Hospital Hamburg-Eppendorf, D-20246 Hamburg, Germany.

Sandra Fuest (S)

Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Hospital Hamburg-Eppendorf, D-20246 Hamburg, Germany.

Ming Yan (M)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.

Christian Knipfer (C)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.

Martin Gosau (M)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.

Frank Walther (F)

Department of Materials Test Engineering (WPT), TU Dortmund University, Baroper Str. 303, D-44227 Dortmund, Germany.

Ralf Smeets (R)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.
Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Hospital Hamburg-Eppendorf, D-20246 Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH